Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers
Open Access
- 17 April 1998
- journal article
- predictive oncology
- Published by Wiley in International Journal of Cancer
- Vol. 79 (2) , 111-115
- https://doi.org/10.1002/(sici)1097-0215(19980417)79:2<111::aid-ijc2>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cancer Cell CyclesScience, 1996
- Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical studyInternational Journal of Cancer, 1996
- Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerBritish Journal of Cancer, 1996
- A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human MelanomaScience, 1995
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Cyclin D1 expression is regulated by the retinoblastoma protein.Proceedings of the National Academy of Sciences, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.Proceedings of the National Academy of Sciences, 1989